Optometrists in Seattle, WA Accepting Medicare
265 Optometrists found. Showing 141 - 160
 Dr. Robert Gander & Associates, Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 401 Ne Northgate Way # 530, Seattle, WA 98125 Phone: 206-364-2273 |
Dr. Pamela J. Bingham, Inc. P.s. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2602 Ne University Village St, Seattle, WA 98105 Phone: 206-522-9323 Fax: 425-897-0406 |
Z Optic Eyecare Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 4720 42nd Ave Sw, Seattle, WA 98116 Phone: 415-297-1751 |
Cannon Eyecare (at Market Optical) Optometrist Medicare: Medicare Enrolled Practice Location: 2602 Ne University Village St, Suite B (at Market Optical), Seattle, WA 98105 Phone: 206-522-9323 Fax: 206-525-3841 |
 Dr. Eric John Bergstrom, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 20 Boston St, Seattle, WA 98109 Phone: 206-282-8120 |
Optometry Medical Group Inc Optometrist Medicare: Medicare Enrolled Practice Location: 1721 22nd Ave, Seattle, WA 98122 Phone: 206-395-2285 Fax: 206-395-2315 |
Dr. Landon John Jones, O.D. Optometrist - Low Vision Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 10330 Meridian Ave N, Suite 370, Seattle, WA 98133 Phone: 206-528-6000 Fax: 206-528-0014 |
Dr. Raymond L Phillips, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4700 42nd Ave Sw Ste 490, Seattle, WA 98116 Phone: 206-932-3277 |
Dr. Mark Hovander, O.D. Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 4115 University Way Ne, #101, Seattle, WA 98105 Phone: 206-633-2000 Fax: 206-633-4857 |
Stephen G Goo, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 8032 35th Ave Ne, Seattle, WA 98115 Phone: 206-523-6676 Fax: 206-523-7900 |
 Davina Kuhnline, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 10330 Meridian Ave N, Suite 370, Seattle, WA 98133 Phone: 206-528-6000 Fax: 206-528-0014 |
Shani Eliza Rerecich, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1600 E. Jefferson St, Ste #202, Seattle, WA 98122 Phone: 425-320-2630 |
Dr. Stephen Nevett And Associates, P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 401 Ne Northgate Way Spc 1101, Seattle, WA 98125 Phone: 972-740-2027 |
Dr. Alan L Kimpton, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1719 Nw Market St, Seattle, WA 98107 Phone: 206-784-2090 Fax: 206-784-8939 |
Dr. Erica Uman, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1101 Madison St Ste 600, Seattle, WA 98104 Phone: 206-215-2020 Fax: 206-215-2022 |
Ballard Optometry, Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 1719 Nw Market St, Seattle, WA 98107 Phone: 206-784-2090 |
Lisbeth A. Faulstich, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9720 4th Ave Ne, Seattle, WA 98115 Phone: 360-883-3000 |
Dr. Robert Gander, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 401 Ne Northgate Way, #530, Seattle, WA 98125 Phone: 206-364-2273 |
Dr. Kristen Sara Griggs, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1660 S Columbian Way, Seattle, WA 98108 Phone: 206-764-2020 Fax: 206-764-2477 |
Michael L Giese, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 10416 5th Ave Ne, Seattle, WA 98125 Phone: 206-517-6700 |
News Archive
Impact of end-stage renal disease (ESRD) Medicare reform explained
The end-stage renal disease (ESRD) Medicare reform measures recently passed by Congress represent the most significant ESRD reforms in decades.
Factor Xa inhibitor Apixaban and antiplatelet therapy after acute coronary syndrome
Data from a phase II study of an investigational drug designed to block formation of blood clots show potential for added protection against a second heart attack or stroke among patients who are already taking state-of-the-art prevention therapy.
Patient enrollment underway in Phase III trial program to evaluate amikacin inhalation solution
Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated patients with Gram-negative pneumonia receiving standard of care intravenous antibiotics.
Watson third quarter net revenue increases 33% to $882.4 million
Watson Pharmaceuticals, Inc. today reported net revenue grew 33 percent for the third quarter ended September 30, 2010 to $882.4 million, compared to $662.1 million in the third quarter 2009. On an adjusted cash basis, net income increased 18 percent to $105.9 million or $0.85 per share, compared to $90.0 million or $0.78 per share in the third quarter 2009.
Increasing physical activity over six years associated with decreased heart failure risk
By analyzing reported physical activity levels over time in more than 11,000 American adults, Johns Hopkins Medicine researchers conclude that increasing physical activity to recommended levels over as few as six years in middle age is associated with a significantly decreased risk of heart failure, a condition that affects an estimated 5 million to 6 million Americans.
› Verified 5 days ago
Physical Therapists
Chiropractors
Occupational Therapists
Speech-Language Pathologists
Optometrists
Audiologists
Podiatrists